We found that MIR17HG was highly expressed in GECs and MIR17HG silencing decreased the expressions of ZO-1, occludin, and claudin-5 and increased the permeability of glioma-conditioned normal BBB. The gene discussed is TJP1; the disease is central nervous system cancer.